TOKYO -- Swiss pharmaceutical company Novartis plans to start mass production of radiopharmaceuticals, a type of next-generation cancer treatment, in Japan in 2026, Nikkei has learned.
The company will install equipment at its plant in Tamba-Sasayama, Hyogo prefecture to create the…